))
Popular Episode - Bob Nelsen on AI, China and the IRA
Manage episode 435643568 series 3571902
Conteúdo fornecido por BioCentury. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por BioCentury ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
This is a previously recorded episode of The BioCentury Show from February 22, 2024. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes.
In a wide-ranging conversation with BioCentury, Bob Nelsen, co-founder and managing director of Arch Venture Partners, said he is excited by the potential for AI to “create a language of biology,” is cautious about investing in China given increasing geopolitical tensions, and is convinced that the U.S. healthcare system could do a far better job of delivering on the promise of rapidly progressing science.
Nelsen, who has helped finance and create more than 150 companies, including 47 that have reached valuations exceeding $1 billion, discussed his conviction that focusing on creating transformational medicines, rather than looking for short-term gains, is a key to success in the life sciences.
View full story: https://www.biocentury.com/article/651502
#biotech #pharma #biopharma #TheBioCenturyShow
0:00 - Introduction
01:59 - The Promise of AI
08:35 - The Inflation Reduction Act
15:38 - China
25:58 - Building Companies Around Big challenges
Capítulos
1. Popular Episode - Bob Nelsen on AI, China and the IRA (00:00:00)
2. The Promise of AI (00:01:59)
3. The Inflation Reduction Act (00:08:35)
4. China (00:15:38)
5. Building Companies Around Big challenges (00:25:58)
17 episódios
Compartilhar
